Has Wungki Park, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,688 in general payments to Wungki Park, MD across 8 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wungki Park, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wungki Park, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wungki Park, MD

Medical Oncology · New York, NYNPI 1457617771

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,268 of the $4,688 with a category attached, or 69.7%. Regeneron accounts for 94.9% of it on its own, with 1 other manufacturer making up the rest. 2024 is the largest year on record at $4,451, more than ten times the $127 reported in 2019. That places this record below the midpoint for medical oncology clinicians in NY, where the typical reported total is $4,912.

$4,688in general payments, 2019–2025

Across 8 payments — averaging $586.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron$4K
Genentech USA, Inc.$238

$25,456,949in research payments, 2019–2025

Across 1,047 payments — averaging $24,314 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Merck$21.7M
Astellas Pharma Inc$3M
Amgen$495K
Astellas Pharma Global Development$284K

What the payments were for

Consulting fees$3,26870%
Travel & lodging$1,05122%
Food & beverage$3698%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron	6	$4,451
Genentech USA, Inc.	2	$238

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Avastin$127

How this compares

$4,688 in reported general payments places this provider in the 45th percentile of 498 medical oncology providers in New York.

See all medical oncology providers in New York →

Medicare billing

Part B allowed, 2024

$65,925

Medicare patients

132

Services billed

553

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ZenpepLipase/Protease/Amylase	33	$98,153
CreonLipase/Protease/Amylase	44	$95,268
EliquisApixaban	24	$15,337
XareltoRivaroxaban	12	$6,900
Ondansetron Hcl	25	$1,991
Prochlorperazine Maleate	27	$875
Gabapentin	28	$141
Pregabalin	13	$136
Pantoprazole Sodium	11	$129
Oxycodone Hcl	15	$120
Potassium Chloride	12	$92
Lorazepam	11	$40

Paid to pharmacies, not to this prescriber.

Other medical oncology in New York

Craig ThompsonNew York$4.8M
Andrew SeidmanNew York$1.3M
Joshua RichterNew York$971K
Edward GelmannNew York$944K
Ghassan Abou-AlfaNew York$825K
Miguel PeralesNew York$769K
Komal JhaveriNew York$642K
Joshua BrodyNew York$492K
Aiwu HeNew York$445K
Raajit RampalNew York$418K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →